MERCY Trial Results
2 essaisEssais extraits du podcast de Rob Mac Sweeney
- 2023MERCYInfection & AntimicrobialsIn 607 critically ill adults with sepsis, continuous meropenem did not reduce death or drug-resistant bacteria at day 28 compared with intermittent dosing.
- 2018Prolonged versus short-term intravenous infusion of antipseudomonal β-lactams in sepsisInfection & AntimicrobialsIn 1876 patients with sepsis, prolonged infusion of antipseudomonal β-lactams reduced all-cause mortality compared with short-term infusion.